Antigenic variations of recent street rabies virus

References

• Baer GM. Rabies – an historical perspective. Infect Agents Dis. 1994 Aug;3(4):168–180.
   PubMedGoogle Scholar
• Fodor I, Grabko VI, Khozinski VV, et al. Nucleotide and deduced amino acid sequences of the glycoprotein gene of rabies virus vaccine strain Vnukovo-32. Arch Virol. 1994;135(3–4):451–459. doi: 10.1007/BF01310030
   PubMed Web of Science ®Google Scholar
• Gao GF. From “A”IV to “Z”IKV: Attacks from emerging and re-emerging pathogens. Cell. 2018 Mar 8;172(6):1157–1159. doi: 10.1016/j.cell.2018.02.025
   PubMed Web of Science ®Google Scholar
• Mumford JA. Vaccines and viral antigenic diversity. Revue Scientifique et Technique (International Office of Epizootics. 2007 Apr;26(1):69–90.
   PubMed Web of Science ®Google Scholar
• Smith DJ, Lapedes AS, de Jong JC, et al. Mapping the antigenic and genetic evolution of influenza virus. Science (New York. NY. 2004 Jul 16;305(5682):371–376. doi: 10.1126/science.1097211
   PubMed Web of Science ®Google Scholar
• Brookes SM, Healy DM, Fooks AR. Ability of rabies vaccine strains to elicit cross-neutralising antibodies. Dev Biol (Basel). 2006;125:185–193.
   PubMedGoogle Scholar
• Nolden T, Banyard AC, Finke S, et al. Comparative studies on the genetic, antigenic and pathogenic characteristics of Bokeloh bat lyssavirus. J Gen Virol. 2014 Aug;95(Pt 8):1647–1653. doi: 10.1099/vir.0.065953-0
   PubMed Web of Science ®Google Scholar
• Hanlon CA, Kuzmin IV, Blanton JD, et al. Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res. 2005 Jul;111(1):44–54. doi: 10.1016/j.virusres.2005.03.009
   PubMed Web of Science ®Google Scholar
• Brookes SM, Parsons G, Johnson N, et al. Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine. 2005 Jul 14;23(32):4101–4109. doi: 10.1016/j.vaccine.2005.03.037
   PubMed Web of Science ®Google Scholar
• Horton DL, Banyard AC, Marston DA, et al. Antigenic and genetic characterization of a divergent African virus, Ikoma lyssavirus. J Gen Virol. 2014 May;95(Pt 5):1025–1032. doi: 10.1099/vir.0.061952-0
   PubMed Web of Science ®Google Scholar
• Badrane H, Bahloul C, Perrin P, et al. Evidence of two lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J Virol. 2001 Apr;75(7):3268–3276. doi: 10.1128/JVI.75.7.3268-3276.2001
   PubMed Web of Science ®Google Scholar
• Kaur M, Garg R, Singh S, et al. Rabies vaccines: where do we stand, where are we heading? Expert Rev Vaccines. 2015 Mar;14(3):369–381. doi: 10.1586/14760584.2015.973403
   PubMed Web of Science ®Google Scholar
• Ajorloo M, Mirzaei H, Sadeghi Y, et al. Evaluation and phylogenetic analysis of regular rabies virus vaccine strains. Arch Iran Med. 2018 Mar 1;21(3):101–110.
   PubMed Web of Science ®Google Scholar
• Patel AC, Upmanyu V, Ramasamy S, et al. Molecular and immunogenic characterization of BHK-21 cell line adapted CVS-11 strain of rabies virus and future prospect in vaccination strategy. Virusdisease. 2015 Dec;26(4):288–296. doi: 10.1007/s13337-015-0285-5
   PubMedGoogle Scholar
• Orlowska A, Zmudzinski JF. Molecular epidemiology of rabies virus in Poland. Arch Virol. 2014 Aug;159(8):2043–2050. doi: 10.1007/s00705-014-2045-z
   PubMed Web of Science ®Google Scholar
• Aghomo HO, Rupprecht CE. Antigenic characterisation of virus isolates from vaccinated dogs dying of rabies. Trop Anim Health Prod. 1990 Nov;22(4):275–280. doi: 10.1007/BF02240413
   PubMed Web of Science ®Google Scholar
• Okoh AE. Antigenic characterization of rabies virus isolates from vaccinated dogs in plateau state, Nigeria. Vet Res Commun. 2000 Apr;24(3):203–211. doi: 10.1023/A:1006412516340
   PubMed Web of Science ®Google Scholar
• Umoh JU, Cox JH, Schneider LG. Antigenic characterization of street rabies virus isolates from Nigeria using monoclonal antibodies. Zentralblatt fur Veterinarmedizin Reihe B Journal of Veterinary Medicine. 1990 May;37(3):222–228.
   PubMedGoogle Scholar
• Wiktor TJ, Koprowski H. Antigenic variants of rabies virus. J Exp Med. 1980 Jul 1;152(1):99–112. doi: 10.1084/jem.152.1.99
   PubMed Web of Science ®Google Scholar
• Dietzschold B, Gore M, Casali P, et al. Biological characterization of human monoclonal antibodies to rabies virus. J Virol. 1990 Jun;64(6):3087–3090.
   PubMed Web of Science ®Google Scholar
• Aghomo HO, Rupprecht CE. Further studies on rabies virus isolated from healthy dogs in Nigeria. Vet Microbiol. 1990 Mar;22(1):17–22. doi: 10.1016/0378-1135(90)90120-K
   PubMed Web of Science ®Google Scholar
• Zanluca C, Aires LR, Mueller PP, et al. Novel monoclonal antibodies that bind to wild and fixed rabies virus strains. J Virol Methods. 2011 Jul;175(1):66–73. doi: 10.1016/j.jviromet.2011.04.019
   PubMed Web of Science ®Google Scholar
• Sureau P, Rollin P, Wiktor TJ. Epidemiologic analysis of antigenic variations of street rabies virus: detection by monoclonal antibodies. Am J Epidemiol. 1983 May;117(5):605–609. doi: 10.1093/oxfordjournals.aje.a113583
   PubMed Web of Science ®Google Scholar
• Hanada K, Suzuki Y, Gojobori T. A large variation in the rates of synonymous substitution for RNA viruses and its relationship to a diversity of viral infection and transmission modes. Mol Biol Evol. 2004 Jun;21(6):1074–1080. doi: 10.1093/molbev/msh109
   PubMed Web of Science ®Google Scholar
• Morimoto K, Hooper DC, Carbaugh H, et al. Rabies virus quasispecies: implications for pathogenesis. Proc. Natl. Acad. Sci. U.S.A.. 1998 Mar 17;95(6):3152–3156. doi: 10.1073/pnas.95.6.3152
   PubMed Web of Science ®Google Scholar
• Chao TY, Ren S, Shen E, et al. SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies. PLoS Negl Trop Dis. 2017 Dec;11(12):e0006133. doi: 10.1371/journal.pntd.0006133
   PubMed Web of Science ®Google Scholar
• Nie J, Wu X, Ma J, et al. Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system. Sci Rep. 2017 Feb 20;7:42769. doi: 10.1038/srep42769
   PubMed Web of Science ®Google Scholar
• Wang W, Nie J, Prochnow C, et al. A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization. Retrovirology. 2013 Feb 6;10:14. doi: 10.1186/1742-4690-10-14
   PubMed Web of Science ®Google Scholar
• Tamura K, Stecher G, Peterson D, et al. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013 Dec;30(12):2725–2729. doi: 10.1093/molbev/mst197
   PubMed Web of Science ®Google Scholar
• Benmansour A, Leblois H, Coulon P, et al. Antigenicity of rabies virus glycoprotein. J Virol. 1991 Aug;65(8):4198–4203.
   PubMed Web of Science ®Google Scholar
• Bunschoten H, Gore M, Claassen IJ, et al. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. J Gen Virol. 1989 Feb;70(Pt 2):291–298. doi: 10.1099/0022-1317-70-2-291
   PubMed Web of Science ®Google Scholar
• Dietzschold B, Wunner WH, Wiktor TJ, et al. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci U.S.A.. 1983 Jan;80(1):70–74. doi: 10.1073/pnas.80.1.70
   PubMed Web of Science ®Google Scholar
• Kuzmina NA, Kuzmin IV, Ellison JA, et al. Conservation of binding epitopes for monoclonal antibodies on the rabies virus glycoprotein. Journal of Antivirals and Antiretrovirals. 2013;5(2):037–043. doi: 10.4172/jaa.1000061
   Google Scholar
• Luo TR, Minamoto N, Ito H, et al. A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope. Virus Res. 1997 Sep;51(1):35–41. doi: 10.1016/S0168-1702(97)00080-4
   PubMed Web of Science ®Google Scholar
• Seif I, Coulon P, Rollin PE, et al. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol. 1985 Mar;53(3):926–934.
   PubMed Web of Science ®Google Scholar
• Horton DL, McElhinney LM, Marston DA, et al. Quantifying antigenic relationships among the lyssaviruses. J Virol. 2010 Nov;84(22):11841–8. doi: 10.1128/JVI.01153-10
   PubMed Web of Science ®Google Scholar